| [1] |
赵堪兴，杨培增. 眼科学[M]. 北京：人民卫士出版社，2008.
|
| [2] |
Nations United. World Population prospects：2004 revision[M]. New York: United Nations, 2005.
|
| [3] |
Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration[J]. Surv Ophthalmol, 1995, 39(5): 367-374.
|
| [4] |
Mitchell P, Korobelnik JF, Lanzetta P, et al. Ranibizumab(Lucentis) in neovascular age-related macular degeneration：evidence from clinical trials[J]. Br J Ophthalmol, 2010, 94(1): 2-13.
|
| [5] |
AREDS. Arandomized，placebo-controlled，clinical trial of high-dose supplementation with vitamins C and E, beta carotene，and zinc for age-related macular degeneration and vision loss: AREDS report No.8[J]. Arch Ophthalmol, 2001, 119(10): 1417-1436.
|
| [6] |
Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes[J]．Am J Opthalmol, 2009, 147(5): 811-815.
|
| [7] |
Fujiwara T, Imamura Y, Margolis R, et al. Enhanced depth imaging optical coherence tomogarphy of the choroid in highly myopic eyes[J]. Am J Ophthalmol, 2009, 148(3): 445-450.
|
| [8] |
Gomi F, Tano Y. Polypoidal choroidal vascolopathy and treatments[J]. Curr Opin Ophthalmol, 2008, 19(3): 208-212.
|
| [9] |
Teschner S, Noack J, Birngruber R, et al. Characterization of leakage activityin exudative chorioretinal disease with three-dimensional confocal angiography [J]. Ophthalmology, 2003, 110(4): 687-697.
|
| [10] |
Imamura Y, Fujiwara T, Margolis R, et al. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopthy[J]. Retina, 2009, 29(10): 1469-1473.
|
| [11] |
Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes[J]. Am J Ophthalmol, 2009, 147(5): 811-815.
|
| [12] |
Manjunath V, Taha M, Fujimoto JG, et al. Choroidal thickness in normal eyes measured using C irrus HD optical coherence tomography[J]. Am J Ophthalmol, 2010, 150(3): 325-329.
|
| [13] |
Ding X, Li J, Zeng J, et al. Choroidal thickness in healthy Chinese subjects[J]. Invest Ophthalmol Vis Sci, 2011, 52(13): 9555-9560.
|
| [14] |
Li XQ, Larsen M, Munch IC. Subfoveal choroidal thickness in relation to sex and axial length in 93 Danish University students[J]. Invest Ophthalmol Vis Sci, 2011, 52(11): 8438-8441.
|
| [15] |
Sogawa K, Nagaoka T, Takahashi A, et al. Relationship betw een choroidal thickness and choroidal circulation in healthy young subjects[J]. Am J Ophthalmol, 2012, 153(6): 1129-1132.
|
| [16] |
Tan CS, Ouyang Y, Ruiz H, et al. Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography [J]. Invest Ophthalmol Vis Sci, 2012, 53(1): 261-266.
|
| [17] |
Fujiwara T, Imamura Y, Margolis R, et al. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes[J]. Am J Ophthalmol, 2009, 148(3): 445-450.
|
| [18] |
Nishida Y, Fujiwara T, Imamura Y, et al. Choroidal thickness and visual acuity in highly myopic eyes[J]. Retina, 2012, 32(7): 1229, 1236.
|
| [19] |
Spaide RF, Goldbaum M, Wong DW, et al. Serous detachment of the retina[J]. Retina, 2003, 23(6): 820-846.
|
| [20] |
Tittl M, Polska E, Kircher K, et al. Topical funds pulsation measurement in patients with active central serous chorio retinopathy[J]. Arch Ophthalmol, 2003, 121(7): 975-978.
|
| [21] |
Tittl M, Maar N, Polska E, et al. Choroidal hemodynamic changes during isometric exercise in patients with inactive central serous chorioretinopathy[J]. Invest Ophthalmol Vis Sci, 2005, 46(12): 4717-4721.
|
| [22] |
Imamura Y, Fujiwara T, Margolis R, et al. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy[J]. Retina, 2009, 29(10): 1469-1473.
|
| [23] |
Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy[J]. Retina, 2011, 31(8): 1603-1608.
|
| [24] |
Anders P, Michael L. Choroidal thichness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorio retinopathy[J]. Acta Ophthalmol, 2012, 90 (8): 738-743.
|
| [25] |
Ichiro M, Tomohiro I, Yukinori S, et al. One year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy[J]. Retina, 2011, 31(9): 1921-1927.
|
| [26] |
Shin JY, Woo SJ, Yu HG, et al. C omparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy[J]. Retina, 2011, 31(1): 119-126.
|
| [27] |
Weinberger D, Kramer M, Priel E, et al. Indocyanine green angiographic findings in nonproliferative diabetic retinopathy[J]. Am J Ophthalmol, 1998, 126( 2): 238-247.
|
| [28] |
Esmaeelpour M, Povazay B, Hermann B, et al. Mapping choroidal and retinal thickness variation in type 2 diabetes using three-dimensional 1060-nm optical coherence tomography[J]. Invest Ophthalmol Vis Sci, 2011, 52( 8): 5311-5316.
|
| [29] |
Esmaeelpour M, Povaay B, Hermann B, et al. Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes[J]. Br J Ophthalmol, 2004, 88 (8): 1060-1063.
|
| [30] |
Schocket LS, Brucker AJ, Niknam RM, et al. Foveolar choroidal hemodynamics in proliferative diabetic retinopathy[J]. Int Ophthalmol, 2004, 25(2): 89-94.
|
| [31] |
Shiragami C, Shiraga F, Matsuo T, et al. Risk factors for diabetic choroidopathy in patients with diabetic retinopathy[J]. Graefes Arch Clin Exp Ophthalmol, 2002, 240( 6): 436-442.
|
| [32] |
Bordaberry MF. Vogt-Koyanagi-Harada disease: diagnosis and treatments update[J]. Curr Opin Ophthalmol, 2010, 21(6): 430-435.
|
| [33] |
Fardeau C, Tran TH, Gharbi B, et al. Retinal fluorescein and indocyanine green angiography and optical coherence tomography in successive stages of Vogt-Koyanagi-Harada disease[J]. Int Ophthalmol, 2007, 27(2/3): 163-172.
|
| [34] |
Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up[J]. Int Ophthalmol, 2007, 27(2/3): 173-182.
|
| [35] |
Maruko I, Iida T, Sugano Y, et al. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 2011, 151(4): 594-603.
|
| [36] |
Fong AH, Li KK, Wong D. Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease[J]．Retina, 2011, 31(3): 502-509.
|
| [37] |
Rao NA. Pathology of Vogt-Koyanagi-Harada disease[J]. Int Ophthalmol, 2007, 27( 2/3): 81-85.
|
| [38] |
杜君，雷方. Vogt-小柳-原田综合征黄斑中心凹脉络膜厚度分析[J]. 眼科新进展，2016, 36( 8): 777-779.
|
| [39] |
Galassi F, Sodi A, Ucci F, et al. Ocular hemodynamics and glaucoma prognosis: a color Doppler imaging study[J]. Arch Ophthalmol, 2003, 121(12): 1711-1715.
|
| [40] |
Grunwald JE, Piltz J, Hariprasad SM, et al. Optic nerve and choroidal circulation in glaucoma[J]. Invest Ophthalmol Vis Sci, 1998, 39(12): 2329-2336.
|
| [41] |
Nicolela MT, Hnik P, Drance SM. Scanning laser Doppler flowmeter study of retinal and optic disk blood flow in glaucomatous patients[J]. Am J Ophthalmol, 1996, 122( 6): 775-783.
|
| [42] |
Jonas JB. Clinical implications of peripapillary atrophy in glaucoma[J]. Curr Opin Ophthalmol, 2005, 16(2): 84-88.
|
| [43] |
Spaide RF. Age-related choroidal atrophy[J]. Am J Ophthamol, 2009, 147(5): 801-810.
|
| [44] |
Pablo LE, Bambo MP, Cameo B, et al. The use of zonal analysis of peripapillary choroidal thickness in primary open-angle glaucoma[J]. Jpn J Ophthalmol, 2018, 62(1): 41-47.
|
| [45] |
Maul EA, Friedman DS, Chang DS, et al. Choroidal thickness measured by spectral domain optical coherence tomography：factors affecting thickness in glaucoma patients[J]. Ophthalmology, 2011, 118(8): 1571-1579.
|
| [46] |
Ho J, Branchini L, Regatieri C, et al. Analysis of normal peripapillary choroidal thickness via spectral domain optical coherence tomography[J]. Ophthalmology, 2011, 118(10): 2001-2007.
|
| [47] |
Mwanza JC, Hochberg JT, Banitt MR, et al. Lack of association between glaucoma and macular choroidal thickness measured with enhanced depth-imaging optical coherence tomography[J]. Invest Ophthalmol Vis Sci, 2011, 52(6): 3430-3435.
|
| [48] |
Ehrlich JR, Peterson J, Parlitsis G, et al. Peripapillary choroidal thickness in glaucoma measured with optical coherence tomography[J]. Exp Eye Res, 2011, 92(3): 189-194.
|
| [49] |
Usui S, Ikuno Y, Miki A, et al. Evaluation of the choroidal thickness using high-penetration optical coherence tomography with long wavelength in highly myopic normal tension glaucoma[J]. Am J Ophthalmol, 2012, 153(1): 10-16.
|
| [50] |
Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy : The Beaver Dam Eye Study[J]. Ophthalmology, 1992, 99(6) : 933-943.
|
| [51] |
Spaide RF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration[J]. Am J Ophthalmol, 2009, 147(4): 644-652.
|
| [52] |
Koizumi H, Yamagishi T, Yamazaki T, et al. Subfoveal choroidal thickness in typical age related macular degeneration and polypoidal choroidal vasculopathy[J]. Graefes Arch Clin Exp Ophthalmol, 2011, 249( 8): 1123-1128.
|
| [53] |
Ashley W, Alison B. Retinal and choroidal thickness in early age-related macular degeneration[J]. Am J Ophthalmol, 2011, 152(6): 1030-1038.
|
| [54] |
Taban M, Williams D, Smith SD, et al. Assessing the reliability of automated OCT retinal thickness measurements in patients with choroidal neovascularization due to agerelated macular degeneration[J]. Ophthalmic Surg Lasers Imaging, 2010, 41(2): 166-174.
|
| [55] |
Sarks SH. Ageing and degeneration in the macular region：a clinic-opathological study[J]. Br J Opthalmol, 1976, 60(5): 324-341.
|